Stylus will use the Eli Lilly and J&J-backed funds to advance its in vivo genetic medicines platform and develop its pipeline ...

Stylus Medicine, Inc. ("Stylus"), a biotechnology company dedicated to developing transformative in vivo genetic medicines, today emerges from stealth with $85 million in financing. Stylus' funding ...

Cambridge, USA-based biotech Stylus Medicine, which says it is dedicated to developing transformative in vivo genetic ...

Stylus Medicine Inc., a biotechnology company dedicated to developing transformative in vivo genetic medicines, has emerged ...

Stylus Medicine is unsheathing, penning a mission to develop next-gen in vivo genetic medicines with $85 million in hand, ...

Industry layoffs continue to accelerate, this time hitting RA Capital’s biotech incubator, according to Stat News ...

Stylus Medicine is developing transformative in vivo genetic medicines to unlock cures. Stylus combines engineered recombinases with non-viral delivery to specifically encode therapeutics.

Stylus Medicine, a startup founded by Patrick Hsu, has raised $85 million to develop a suite of technologies that it believes ...

If you’re a fan of The White Lotus, you’ve probably dreamed about a wellness escape as luxurious as the show’s fictional Thai ...

Dr Ashis Acharya, Senior Consultant Orthopaedics and Sports Medicine at Sir Ganga Ram Hospital ... He advises, “Gentle hand and wrist exercises, switching to a stylus or voice input, and regular ...